Efavirenz-based regimens

DRUG2 trials

Sponsors

Bamrasnaradura Infectious Diseases Institute, Fundação Bahiana de Infectologia

Conditions

CD4 Cell CountsSeverely Immunocompromised HIV PatientsTreatment Failure, HIV or AIDS

Phase 2

Impact of a Dolutegravir-based Regimen on Early Mortality of AIDS Patients

CompletedNCT01837277

Fundação Bahiana de InfectologiaSeverely Immunocompromised HIV Patients

Start: 2017-12-15End: 2021-09-30Updated: 2023-12-14

Unknown Phase

Effectiveness of Efavirenz-based Regimen in HIV-1-infected Patients With Nevirapine Hypersensitivity

CompletedNCT01044810

Bamrasnaradura Infectious Diseases InstituteCD4 Cell Counts, Treatment Failure, HIV or AIDS

Start: 2010-01-31End: 2010-03-31Updated: 2011-03-15